Tuesday July 17, 2018
Home India Don’t f...

Don’t forget 1971 Bangladesh War: M. Venkaiah Naidu warns Pakistan for “Aiding and Abetting Terror”

According to Naidu, "Our neighbour should understand that aiding and abetting terror will not help them, they should recall what happened in 1971... Terrorism is the enemy of humanity, it has no religion."

0
//
85
M Venkaiah Naidu
NDA's Vice Presidential candidate M. Venkaiah Naidu on Sunday reminded Pakistan not to forget what happened in 1971. Wikimedia
Republish
Reprint
  • NDA’s Vice Presidential candidate M. Venkaiah Naidu on Sunday reminded Pakistan not to forget what happened in 1971 in a reference to the Bangladesh War
  • Naidu also criticized Pakistan for “mixing terrorism with religion” as its state policy
  • The former Union Minister asserted that Kashmir is an integral part of India and “not an inch” of it will be ceded

New Delhi, July 23, 2017:  Hitting out at Pakistan for “aiding and abetting terror”, NDA’s Vice Presidential candidate M. Venkaiah Naidu on Sunday reminded it not to forget what happened in 1971 in a reference to the Bangladesh War in which it faced a humiliating defeat.

Naidu was addressing the annual Kargil Parakram Parade here, held in remembrance of soldiers killed in a war with Pakistan in Jammu and Kashmir’s Kargil sector in 1999.

ALSO READPakistan releases 78 Indians imprisoned in Karachi Jail

“Our neighbour should understand that aiding and abetting terror will not help them, they should recall what happened in 1971… Terrorism is the enemy of humanity, it has no religion,” he said.

Criticising Pakistan for “mixing terrorism with religion” as its state policy, the former Union Minister asserted that Kashmir is an integral part of India and “not an inch” of it will be ceded.

He also urged Pakistan to shun the path of confrontation.

“We are a peace loving people. We never attacked any country. We don’t want war, we don’t want confrontation. We want to have peace and good relations with our neighbours, but they should also reciprocate,” Naidu said. (IANS)

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)